| RS2122132718 |
APOE
|
Health Risk |
Pathogenic |
Familial type 3 hyperlipoproteinemia, Familial type 3 hyperlipoproteinemia |
| RS2122137937 |
APOE
|
Health Risk |
Likely pathogenic |
Familial type 3 hyperlipoproteinemia, Familial type 3 hyperlipoproteinemia |
| RS2122139471 |
PAX1
|
Health Risk |
Likely pathogenic |
— |
| RS2122139711 |
PAX1
|
Health Risk |
Likely pathogenic |
Craniofacial microsomia, Craniofacial microsomia |
| RS2122142757 |
BCKDHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2122142979 |
BCKDHA
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2122143379 |
BCKDHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS2122143393 |
BCKDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease |
| RS2122146208 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2122146680 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2122194539 |
CEACAM16
|
Health Risk |
Likely pathogenic |
Ear malformation, Ear malformation |
| RS2122197253 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS2122202540 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS2122203804 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Colorectal cancer |
| RS2122211012 |
APOC2
|
Health Risk |
Pathogenic |
APOLIPOPROTEIN C-II (TORONTO), Familial apolipoprotein C-II deficiency |
| RS2122219766 |
MKKS
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 6, Bardet-Biedl syndrome 6 |
| RS2122220042 |
MKKS
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome, McKusick-Kaufman syndrome |
| RS2122220131 |
MKKS
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, McKusick-Kaufman syndrome |
| RS2122223967 |
MKKS
|
Health Risk |
Pathogenic |
McKusick-Kaufman syndrome, Bardet-Biedl syndrome |
| RS2122226112 |
MKKS
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, McKusick-Kaufman syndrome |
| RS2122229308 |
KIZ
|
Health Risk |
Pathogenic |
— |
| RS2122232591 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Colorectal cancer |
| RS2122232967 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS2122233990 |
MKKS
|
Health Risk |
Pathogenic |
McKusick-Kaufman syndrome, Bardet-Biedl syndrome |
| RS2122234051 |
MKKS
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, McKusick-Kaufman syndrome |
| RS2122234387 |
MKKS
|
Health Risk |
Pathogenic |
McKusick-Kaufman syndrome, Bardet-Biedl syndrome |
| RS2122234652 |
MKKS
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, McKusick-Kaufman syndrome |
| RS2122235204 |
MKKS
|
Health Risk |
Likely pathogenic |
— |
| RS2122235362 |
MKKS
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 6, McKusick-Kaufman syndrome |
| RS2122235619 |
MKKS
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, McKusick-Kaufman syndrome |
| RS2122236167 |
MKKS
|
Health Risk |
Pathogenic |
McKusick-Kaufman syndrome, Bardet-Biedl syndrome |
| RS2122236468 |
MKKS
|
Health Risk |
Pathogenic |
McKusick-Kaufman syndrome, Bardet-Biedl syndrome |
| RS2122243742 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS2122245228 |
RBCK1
|
Health Risk |
Pathogenic |
Polyglucosan body myopathy type 1, Polyglucosan body myopathy type 1 |
| RS2122245690 |
RBCK1
|
Health Risk |
Pathogenic |
Polyglucosan body myopathy 1 with immunodeficiency, Polyglucosan body myopathy 1 with immunodeficiency |
| RS2122248224 |
FECH
|
Health Risk |
Pathogenic |
— |
| RS2122250926 |
FECH
|
Health Risk |
Pathogenic |
— |
| RS2122251187 |
FECH
|
Health Risk |
Likely pathogenic |
— |
| RS2122268166 |
RBCK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Polyglucosan body myopathy type 1, Polyglucosan body myopathy 1 without immunodeficiency |
| RS2122268456 |
RBCK1
|
Health Risk |
Pathogenic |
Polyglucosan body myopathy 1 without immunodeficiency, Polyglucosan body myopathy 1 without immunodeficiency |
| RS2122274245 |
ITPA
|
Health Risk |
Likely pathogenic |
Inosine triphosphatase deficiency, Inosine triphosphatase deficiency |
| RS2122281705 |
RBCK1
|
Health Risk |
Pathogenic |
Polyglucosan body myopathy type 1, Polyglucosan body myopathy type 1 |
| RS2122282189 |
RBCK1
|
Health Risk |
Pathogenic |
Polyglucosan body myopathy type 1, Polyglucosan body myopathy type 1 |
| RS2122284554 |
FECH
|
Health Risk |
Pathogenic |
— |
| RS2122284871 |
FECH
|
Health Risk |
Pathogenic |
— |
| RS2122290201 |
PRR12
|
Health Risk |
Pathogenic |
— |
| RS2122294765 |
PRR12
|
Health Risk |
Likely pathogenic |
complex microphthalmia, complex microphthalmia |
| RS2122296521 |
PRR12
|
Health Risk |
Likely pathogenic |
complex microphthalmia, complex microphthalmia |
| RS2122298859 |
PRR12
|
Health Risk |
Pathogenic |
Neuroocular syndrome, Neuroocular syndrome |
| RS2122299732 |
PRR12
|
Health Risk |
Likely pathogenic |
Neuroocular syndrome, Neuroocular syndrome |
| RS2122303487 |
PRR12
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroocular syndrome 1, Neuroocular syndrome 1 |
| RS2122304074 |
PRR12
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroocular syndrome, Neuroocular syndrome |
| RS2122304134 |
PRR12
|
Health Risk |
Pathogenic |
— |
| RS2122309575 |
PRR12
|
Health Risk |
Pathogenic |
Neuroocular syndrome, Neuroocular syndrome |
| RS2122310534 |
KIZ
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2122311106 |
PRR12
|
Health Risk |
Pathogenic |
Neuroocular syndrome 1, Neuroocular syndrome 1 |
| RS2122315348 |
PNKP
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS2122315641 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS2122317324 |
PNKP
|
Health Risk |
Likely pathogenic |
— |
| RS2122319377 |
PNKP
|
Health Risk |
Likely pathogenic |
— |
| RS2122319422 |
PNKP
|
Health Risk |
Pathogenic |
Microcephaly, seizures |
| RS2122319491 |
PNKP
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS2122320829 |
FECH
|
Health Risk |
Likely pathogenic |
— |
| RS2122322383 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS2122324210 |
PNKP
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS2122328391 |
ITPA
|
Health Risk |
Likely pathogenic |
Inosine triphosphatase deficiency, Inosine triphosphatase deficiency |
| RS2122328682 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS2122329109 |
PNKP
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS2122329859 |
FECH
|
Health Risk |
Pathogenic |
— |
| RS2122329969 |
PPP2R1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Houge-Janssens syndrome 2, Houge-Janssens syndrome 2 |
| RS2122333424 |
PNKP
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS2122333654 |
RBCK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Polyglucosan body myopathy type 1, Polyglucosan body myopathy type 1 |
| RS2122334423 |
PPP2R1A
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2122334663 |
PPP2R1A
|
Health Risk |
Pathogenic |
Houge-Janssens syndrome 2, Houge-Janssens syndrome 2 |
| RS2122334749 |
PNKP
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2B2, Charcot-Marie-Tooth disease type 2B2 |
| RS2122336841 |
ARHGAP35
|
Health Risk |
Likely pathogenic |
Martsolf syndrome 1, Martsolf syndrome 1 |
| RS2122337413 |
PPP2R1A
|
Health Risk |
Pathogenic |
Houge-Janssens syndrome 2, Houge-Janssens syndrome 2 |
| RS2122344493 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS2122346498 |
ITPA
|
Health Risk |
Pathogenic/Likely pathogenic |
Inosine triphosphatase deficiency, Infantile epileptic dyskinetic encephalopathy |
| RS2122348874 |
RBCK1
|
Health Risk |
Likely pathogenic |
Polyglucosan body myopathy 1 without immunodeficiency, Polyglucosan body myopathy type 1 |
| RS2122349615 |
RBCK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Polyglucosan body myopathy type 1, Polyglucosan body myopathy 1 without immunodeficiency |
| RS2122350869 |
PPP2R1A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2122357230 |
FECH
|
Health Risk |
Likely pathogenic |
Protoporphyria, erythropoietic |
| RS2122359122 |
PRR12
|
Health Risk |
Pathogenic |
— |
| RS2122360528 |
PPP2R1A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2122376439 |
BMP2
|
Health Risk |
Pathogenic |
— |
| RS2122376594 |
TGM6
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 35, Spinocerebellar ataxia type 35 |
| RS2122376761 |
PRR12
|
Health Risk |
Pathogenic/Likely pathogenic |
complex microphthalmia, Neuroocular syndrome 1 |
| RS2122377023 |
BMP2
|
Health Risk |
Pathogenic |
— |
| RS2122386880 |
FECH
|
Health Risk |
Pathogenic |
— |
| RS2122389370 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Colorectal cancer |
| RS2122390232 |
PRR12
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroocular syndrome, Neuroocular syndrome 1 |
| RS2122390899 |
BMP2
|
Health Risk |
Pathogenic |
— |
| RS2122396524 |
ITPA
|
Health Risk |
Pathogenic/Likely pathogenic |
Inosine triphosphatase deficiency, Developmental and epileptic encephalopathy |
| RS2122409537 |
TGM6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2122429764 |
FTL
|
Health Risk |
Likely pathogenic |
Hereditary hyperferritinemia with congenital cataracts, Neuroferritinopathy |
| RS2122429855 |
FTL
|
Health Risk |
Likely pathogenic |
Neuroferritinopathy, Hereditary hyperferritinemia with congenital cataracts |
| RS2122429938 |
NARS1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with microcephaly, impaired language |
| RS2122431077 |
NARS1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with microcephaly, impaired language |
| RS2122436083 |
FTL
|
Health Risk |
Pathogenic |
Neuroferritinopathy, Hereditary hyperferritinemia with congenital cataracts |